| Literature DB >> 31602164 |
Jia-Bin Wang1, Zhi-Yu Liu1, Qi-Yue Chen1, Qing Zhong1, Jian-Wei Xie1, Jian-Xian Lin1, Jun Lu1, Long-Long Cao1, Mi Lin1, Ru-Hong Tu1, Ze-Ning Huang1, Ju-Li Lin1, Hua-Long Zheng1, Si-Jin Que1, Chao-Hui Zheng1, Chang-Ming Huang1, Ping Li1.
Abstract
BACKGROUND: Robotic surgery has been considered to be significantly better than laparoscopic surgery for complicated procedures. AIM: To explore the short-term effect of robotic and laparoscopic spleen-preserving splenic hilar lymphadenectomy (SPSHL) for advanced gastric cancer (GC) by Huang's three-step maneuver.Entities:
Keywords: Advanced gastric cancer; Dissection of splenic hilar lymph node; Huang’s three-step maneuver; Laparoscopic surgery; Propensity score matching; Robotic surgery
Mesh:
Year: 2019 PMID: 31602164 PMCID: PMC6785519 DOI: 10.3748/wjg.v25.i37.5641
Source DB: PubMed Journal: World J Gastroenterol ISSN: 1007-9327 Impact factor: 5.742
General clinical and pathological data of patients
| Age, yr | 55.3 ± 10.4 | 56.9 ± 10.6 | 0.424 | 55.3 ± 10.4 | 55.1 ± 11.5 | 0.925 | ||||
| Sex | 0.345 | 0.615 | ||||||||
| Female | 6 | 17.1 | 156 | 25.7 | 6 | 17.1 | 17 | 12.1 | ||
| Male | 29 | 82.9 | 452 | 74.3 | 29 | 82.9 | 123 | 87.9 | ||
| BMI, kg/m2[ | 23.0 ± 2.7 | 22.2 ± 3.0 | 0.152 | 23.0 ± 2.7 | 23.1 ± 3.0 | 0.858 | ||||
| ASA score | 0.014 | 0.944 | ||||||||
| I | 4 | 11.4 | 186 | 30.6 | 4 | 11.4 | 19 | 13.6 | ||
| II | 28 | 80.0 | 401 | 65.9 | 28 | 80.0 | 109 | 77.8 | ||
| III | 3 | 8.6 | 21 | 3.5 | 3 | 8.6 | 12 | 8.6 | ||
| cT classification | 0.037 | 0.211 | ||||||||
| T2 | 10 | 28.6 | 100 | 16.4 | 10 | 28.6 | 22 | 15.7 | ||
| T3 | 15 | 42.9 | 207 | 34.1 | 15 | 42.9 | 69 | 49.3 | ||
| T4a | 10 | 28.6 | 301 | 49.5 | 10 | 28.6 | 49 | 35.0 | ||
| cN classification | 0.483 | 0.541 | ||||||||
| N0 | 13 | 37.1 | 212 | 34.8 | 13 | 37.1 | 57 | 40.7 | ||
| N1 | 14 | 40.0 | 187 | 30.6 | 14 | 40.0 | 39 | 27.9 | ||
| N2 | 4 | 11.4 | 122 | 20.0 | 4 | 11.4 | 21 | 15.0 | ||
| N3 | 4 | 11.4 | 89 | 14.6 | 4 | 11.4 | 23 | 16.4 | ||
| cTNM stage | 0.094 | 0.137 | ||||||||
| IB | 2 | 5.7 | 55 | 9.0 | 2 | 5.7 | 13 | 9.3 | ||
| IIA | 7 | 20.0 | 106 | 17.4 | 7 | 20.0 | 18 | 12.9 | ||
| IIB | 13 | 37.1 | 104 | 17.1 | 13 | 37.1 | 31 | 22.1 | ||
| IIIA | 7 | 20.0 | 137 | 22.5 | 7 | 20.0 | 22 | 15.7 | ||
| IIIB | 3 | 8.6 | 109 | 17.9 | 3 | 8.6 | 29 | 20.7 | ||
| IIIC | 3 | 8.6 | 97 | 16.0 | 3 | 8.6 | 27 | 19.3 | ||
| Depth of invasion | 0.201 | 0.617 | ||||||||
| pT1a | 5 | 14.3 | 31 | 5.1 | 5 | 14.3 | 10 | 7.1 | ||
| pT1b | 4 | 11.4 | 52 | 8.6 | 4 | 11.4 | 24 | 17.1 | ||
| pT2 | 2 | 5.7 | 55 | 9 | 2 | 5.7 | 10 | 7.1 | ||
| pT3 | 16 | 45.7 | 283 | 46.5 | 16 | 45.7 | 57 | 40.7 | ||
| pT4a | 8 | 22.9 | 187 | 30.8 | 8 | 22.9 | 39 | 27.9 | ||
| Metastatic LNs | 0.308 | 0.649 | ||||||||
| N0 | 16 | 45.7 | 194 | 31.9 | 16 | 45.7 | 54 | 38.6 | ||
| N1 | 6 | 17.1 | 174 | 28.7 | 6 | 17.1 | 20 | 14.3 | ||
| N2 | 6 | 17.1 | 120 | 19.7 | 6 | 17.1 | 23 | 16.4 | ||
| N3 | 7 | 20.0 | 120 | 19.7 | 7 | 20.0 | 43 | 30.7 | ||
| pTNM stage | 0.038 | 0.102 | ||||||||
| IA | 7 | 20.0 | 44 | 7.2 | 7 | 20.0 | 29 | 20.7 | ||
| IB | 3 | 8.6 | 45 | 7.4 | 3 | 8.6 | 8 | 5.7 | ||
| IIA | 6 | 17.1 | 91 | 15.0 | 6 | 17.1 | 23 | 16.4 | ||
| IIB | 6 | 17.1 | 93 | 15.3 | 6 | 17.1 | 16 | 11.4 | ||
| IIIA | 6 | 17.1 | 122 | 20.1 | 6 | 17.1 | 8 | 5.7 | ||
| IIIB | 2 | 5.7 | 149 | 24.5 | 2 | 5.7 | 31 | 22.1 | ||
| IIIC | 5 | 14.3 | 64 | 10.5 | 5 | 14.3 | 25 | 17.9 | ||
| Charlson score | 0.467 | 0.132 | ||||||||
| 0 | 25 | 71.5 | 439 | 72.2 | 25 | 71.5 | 90 | 64.3 | ||
| 1 | 6 | 17.1 | 129 | 21.2 | 6 | 17.1 | 43 | 30.7 | ||
| ≥2 | 4 | 11.4 | 40 | 6.6 | 4 | 11.4 | 7 | 5.0 | ||
| Primary site | 0.458 | 0.335 | ||||||||
| Upper | 21 | 60.0 | 402 | 66.1 | 21 | 60.0 | 96 | 68.6 | ||
| Middle | 14 | 40.0 | 206 | 33.9 | 14 | 40.0 | 44 | 31.4 | ||
Values are expressed as the mean ± SD. RSPSHL: Robotic spleen-preserving splenic hilar lymphadenectomy; LSPSHL: Laparoscopic spleen-preserving splenic hilar lymphadenectomy; BMI: Body mass index; ASA: American Society of Anesthesiologists; LN: Lymph node.
Operative outcomes after propensity score matching
| Total operative time, min | 221.3 ± 40.3 | 189.1 ± 43.8 | <0.001 | ||
| Docking time, min | 30 (26-34) | - | |||
| OR time, min | 186.0 ± 35.3 | 189.1 ± 43.8 | 0.698 | ||
| EBL, mL | 13.7 ± 4.3 | 62.4 ± 29.3 | <0.001 | ||
| SHDT, min | 20.4 ± 4.5 | 24.1 ± 8.9 | 0.018 | ||
| First step, min | 8.4 ± 3.5 | 8.7 ± 4.0 | 0.685 | ||
| Second step, min | 6.7 ± 2.6 | 9.8 ± 5.6 | 0.002 | ||
| Third step, min | 5.2 ± 2.1 | 5.6 ± 3.0 | 0.458 | ||
| SHBL, mL | 2.2 ± 1.9 | 10.0 ± 4.5 | <0.001 | ||
| No. of SGVs | 3.5 ± 1.2 | 3.6 ± 1.1 | 0.637 | ||
| No. of PGAs (yes) | 22 | 62.9 | 81 | 57.9 | 0.591 |
| No. of SUPAs (yes) | 4 | 11.4 | 20 | 14.3 | 0.870 |
| No. of SLPAs (yes) | 1 | 2.9 | 7 | 5 | 0.928 |
| Terminal branches of SpA | 0.754 | ||||
| Concentrated type | 23 | 65.7 | 88 | 62.9 | |
| Distributed type | 12 | 34.3 | 52 | 37.1 | |
| Splenic injury | 3 | 8.6 | 19 | 13.6 | 0.608 |
| Vascular injury | 7 | 20 | 17 | 12.1 | 0.350 |
| No.10 metastatic LN | 4 | 11.4 | 15 | 10.7 | 0.855 |
| No.10 retrieved LN | 3.1 ± 1.4 | 3.3 ± 2.5 | 0.650 | ||
| Total retrieved LNs | 37.8 ± 13.1 | 40.6 ± 13.6 | 0.274 |
Values are the mean ± SD.
Values are medians (IQR). Operative total time = Docking time + operation time. RSPSHL: Robotic spleen-preserving splenic hilar lymphadenectomy; LSPSHL: Laparoscopic spleen-preserving splenic hilar lymphadenectomy; OR time: Operation time; EBL: Estimated blood loss; SHDT: Splenic hilar dissection time; SHBL: Splenic hilar blood loss; SGV: Short gastric vessel; PGA: Post-gastric artery; SUPA: Splenic upper pole artery; SLPA: Splenic lower pole artery; SpA: Splenic artery.
Noncompliance rate of nodal dissection between robotic spleen-preserving splenic hilar lymphadenectomy and laparoscopic spleen-preserving splenic hilar lymphadenectomy
| cT classification | |||||
| cT2 | 3 | 7 | 6 | 16 | 0.791 |
| cT3 | 6 | 9 | 31 | 39 | 0.761 |
| cT4 | 4 | 6 | 19 | 29 | 0.741 |
| cN classification | |||||
| cN0 | 4 | 9 | 22 | 36 | 0.868 |
| cN1 | 6 | 8 | 15 | 23 | 0.825 |
| cN2 | 2 | 2 | 11 | 10 | 0.647 |
| cN3 | 1 | 3 | 8 | 15 | 0.848 |
| cTNM stage | |||||
| I | 1 | 1 | 5 | 8 | 1.000 |
| II | 9 | 16 | 18 | 31 | 0.950 |
| III | 3 | 5 | 33 | 45 | 0.909 |
| BMI, kg/m2 | |||||
| < 25 | 11 | 14 | 38 | 68 | 0.449 |
| ≥ 25 | 2 | 8 | 18 | 16 | 0.139 |
| Total | 13 | 22 | 56 | 84 | 0.757 |
RSPSHL: Robotic spleen-preserving splenic hilar lymphadenectomy; LSPSHL: Laparoscopic spleen-preserving splenic hilar lymphadenectomy; BMI: Body mass index.
Short-term operative outcomes and postoperative complications according to the Clavien–Dindo classification
| Time to ambulation, d | 2.4 ± 0.9 | 2.1 ± 1.0 | 0.107 | ||
| Flatus passage, d | 3.2 ± 0.9 | 3.5 ± 1.3 | 0.199 | ||
| Liquid diet, d | 4.8 ± 1.1 | 5.4 ± 1.7 | 0.049 | ||
| Soft diet, d | 7.0 ± 2.4 | 7.5 ± 1.5 | 0.125 | ||
| Drain removal, d | 9.2 ± 2.1 | 9.6 ± 2.0 | 0.296 | ||
| Nasojejunal tube removal, d | 3.9 ± 1.6 | 4.8 ± 2.5 | 0.044 | ||
| LOS, d | 14.7 ± 13.4 | 14.4 ± 11.5 | 0.894 | ||
| Overall complications | 5 | 14.3 | 25 | 17.9 | 0.616 |
| Grade I–II | 3 | 8.6 | 17 | 12.1 | 0.632 |
| Anastomotic fistula | 2 | 5.7 | 3 | 2.1 | |
| Digestive hemorrhage | - | 1 | 0.7 | ||
| Lymphatic fistula | - | 6 | 4.3 | ||
| Intestinal obstruction | - | 1 | 0.7 | ||
| Intraperitoneal infection | 1 | 2.9 | 4 | 2.9 | |
| Wound infection | - | 1 | 0.7 | ||
| Fat liquefaction | - | 1 | 0.7 | ||
| Grade III-IV | 2 | 5.7 | 8 | 5.7 | 1 |
| Anastomotic fistula | - | 1 | 0.7 | ||
| Digestive hemorrhage | 1 | 2.9 | 3 | 2.1 | |
| Lymphatic fistula | - | 2 | 1.4 | ||
| Intestinal obstruction | - | 1 | 0.7 | ||
| Intraperitoneal infection | 1 | 2.9 | 1 | 0.7 | |
| 30-day mortality | 0 | 0 | |||
| In-hospital mortality | 0 | 0 |
Values are the mean ± SD. The most severe complication was noted in the cases in which more than one complication occurred in a patient. RSPSHL: Robotic spleen-preserving splenic hilar lymphadenectomy; LSPSHL: Laparoscopic spleen-preserving splenic hilar lymphadenectomy; LOS: Length of stay.
Time difference between the first and second steps among robotic spleen-preserving splenic hilar lymphadenectomy patients
| Total RSPSHL ( | 8.4 ± 3.5 | 6.7 ± 2.6 | 0.024 |
| EG ( | 10.0 ± 3.4 | 7.5 ± 2.6 | 0.013 |
| LG ( | 6.3 ± 2.3 | 5.8 ± 2.2 | 0.548 |
Values are the mean ± SD. EG: Early group; LG: Late group; RSPSHL: Robotic spleen-preserving splenic hilar lymphadenectomy.
Figure 1Cost analysis between different groups and subgroups. RSPSHL: Robotic spleen-preserving splenic hilar lymphadenectomy; LSPSHL: Laparoscopic spleen-preserving splenic hilar lymphadenectomy; EG: Early group; LG: Late group.
Figure 2Unadjusted (A) and adjusted (B) regression models of robotic surgery via Huang's three-step maneuver and complications. 1Adjusted for: age, sex, body mass index, American Society of Anesthesiologists class, cT, cN, post-gastric artery, short gastric vessels, splenic upper pole artery, splenic lower pole artery, and the terminal branches of the splenic artery. BMI: Body mass index; ASA: American Society of Anesthesiologists; SGV: Short gastric vessel; PGA: Post-gastric artery; SUPA: Splenic upper pole artery; SLPA: Splenic lower pole artery; SpA: Splenic artery; SHDT: Splenic hilar dissection time; SHBL: Splenic hilar blood loss.